Common diabetes drug promotes development of brain stem cells

| July 9, 2012
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Researchers at The Hospital for Sick Children (SickKids) have found that metformin, a drug commonly used to treat Type II diabetes, can help trigger the pathway used to instruct stem cells in the brain to become neural (nerve) cells. Brain stem cells and the neural cells they generate play a role in the repair of the injured or degenerating brain.  This study suggests a novel therapeutic approach to treating people with brain injuries or potentially even neurodegenerative diseases.

View the original article here: Common diabetes drug promotes development of brain stem cells – HealthCanal.com

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend